Longitude Capital Partners, LLC

Longitude Capital Partners, LLC has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Esperion Therapeutics, Inc. and Collegium Pharmaceutical, Inc. Between 1 July 2013 and 8 December 2017, the trades on record add up to 24 filings.

Market trades split into 4 purchases (€4.5M) and 16 sales (€27.8M). Taken together, the sales exceed the purchases by €23.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2017 alone, the filings show no purchases and 2 sales.

A typical purchase (the median) is worth €1.1M.

The latest filing, published on 12 December 2017, reports an open-market sale of €14.4M in Collegium Pharmaceutical, Inc. The last purchase on record was published on 14 May 2015, which is 4,197 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.